On September 11, 2023, Jeff Frelick, the CEO of Bone Biologics Corp (NASDAQ:BBLG), purchased 9,500 shares of the company, marking a significant insider buying activity.
Bone Biologics CEO Jeff Frelick joins Natalie Stoberman from the Proactive studios to discuss the latest progress in its pilot clinical trial for the NB1.
Letter to the editor: Frelick will go far in MLB triblive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from triblive.com Daily Mail and Mail on Sunday newspapers.